Related Experiment Video

Updated: Aug 7, 2026

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
10:45

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement

Published on: July 26, 2017

Myostatin: biology and clinical relevance

Gilles Carnac1, Stéphanie Ricaud, Barbara Vernus

  • 1Adult stem cells and Facio Scapulo Humeral dystrophy, CRBM, CNRS FRE 2593, 1919 Route de Mende, 34293 Montpellier Cedex 5, France.

Mini Reviews in Medicinal Chemistry
|July 18, 2006
PubMed

Insights

Myostatin normally limits muscle growth. Blocking this protein offers a promising strategy for treating muscle-wasting diseases, with potential therapeutic benefits in humans.

Area of Science:

  • Muscle biology
  • Molecular regulation
  • Therapeutic development

Background:

  • Myostatin functions as a key negative regulator of skeletal muscle mass.
  • Recent biological insights highlight the potential of targeting the myostatin pathway for therapeutic interventions.
  • Understanding myostatin's role is crucial for developing treatments for muscle atrophy.

Purpose of the Study:

  • To present the scientific rationale for investigating anti-myostatin therapies.
  • To explore the potential of myostatin pathway antagonism in human muscle-wasting conditions.
  • To support the clinical evaluation of novel treatments for muscle loss.

Main Methods:

  • Review of current myostatin pathway biology.
  • Analysis of preclinical data on myostatin inhibition.
  • Assessment of the potential for clinical translation.

Main Results:

  • Myostatin pathway antagonism demonstrates significant potential for increasing muscle mass.
  • Evidence suggests feasibility of targeting myostatin in human disease contexts.
  • Therapeutic strategies against myostatin are advancing.

Conclusions:

  • Antagonizing the myostatin pathway is a viable therapeutic strategy for muscle-wasting disorders.
  • Further evaluation of anti-myostatin therapies in humans is warranted.
  • This approach holds promise for patients suffering from muscle loss.

More Related Videos

Preparation of Primary Myogenic Precursor Cell/Myoblast Cultures from Basal Vertebrate Lineages07:51

Preparation of Primary Myogenic Precursor Cell/Myoblast Cultures from Basal Vertebrate Lineages

Published on: April 30, 2014

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Overview of Muscle Tissues01:25

Overview of Muscle Tissues

The human body has three types of muscle tissue: skeletal, smooth, and cardiac. Each class has unique properties that enable them to perform specific functions. However, all muscle tissues share certain properties, including elasticity, contractility, and excitability. 
Elasticity
Elasticity is the ability of muscles to stretch and return to their original shape. This property is partly due to elastic fibers — macromolecules that run through the muscles. These fibers are firm and resilient,...